Clinical Trial Update: Elecsys HE4 Chinese Reference Value Study

View source ↗

Summary

Clinical trial assessing reference values for the HE4 biomarker (Elecsys HE4) in a Chinese population with ovarian cancer; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Ovarian Cancer | Status: COMPLETED